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Abstract The mechanical features of and biologic
response to using distraction osteogenesis with the circular
external fixator are the unique aspects of Ilizarov’s con-
tribution that allows deformity correction and reconstruc-
tion of bone defects. We present a retrospective study of 20
patients who suffered from a variety of benign tumours for
which external fixators (EF) were used to treat deformity,
bone loss, and limb-length discrepancy. A total of 26 bony
segments in twenty patients (10 males, 10 females; mean
age 17 years; range 7–58 years) were treated with EF for
residual problems from the tumour itself (primary treat-
ment) in 8 patients and for complications related to the
primary surgery (secondary treatment) in 12 patients.
Histological diagnoses were Ollier’s disease (n = 4),
Fibrous Dysplasia (n = 5), Congenital multiple exostosis
(n = 5), giant cell tumour (n = 2) and one case for
chondromyxoid fibroma, desmoid fibroma, chondroma and
unicameral bone cyst. Various types of external fixators
used to treat these problems. These were Ilizarov, unilateral
fixator, multiaxial correction frame (Biomet, Parsippany,
NJ), Taylor spatial frame (Memphis, TN) and smart
correction multiaxial frame. The mean follow-up time was
69.5 months (range 35–108 months). The mean external
fixation time was 159.5 days (range 27–300 days). The
mean external fixation index was 67.4 days/cm (12–610) in
26 limbs who underwent distraction osteogenesis. The
mean length of distraction was 4.9 cm (range 0.2–14 cm).
At final follow-up, all patients had returned to normal
activities. Complications were in the form of knee
arthrodesis in one patient, pin tract infection in six and
residual shortening in eight patients. The use of EF and the
principles of distraction osteogenesis, in the management
of problems associated with benign bone tumours and
related surgery yields successful results especially in young
patients. With this approach, the risk for recurrence of
shortening and deformity may be minimized with over-
correction or over-lengthening as dictated by preoperative
planning.
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Introduction
The management of limb deformity, shortening and bone
defects in the treatment of benign tumours is a major
challenge [1, 2]. The radical and aggressive nature of
surgical therapy has to be balanced with the treatment-
related morbidity, i.e. complications, the need for recon-
structive stabilization and potential functional deficit. The
decision is a challenge for the orthopaedic surgeon [3].
Conventional methods of correcting deformity and limb-
length inequality, such as shortening, single or multiple
osteotomies or epiphysiodesis are limited in their scope and
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often unpredictable or unsatisfactory. Alternative methods
of treating bone defects include free autograft, vascularized
bone graft, allograft, artificial bone substitutes and pros-
theses [4]. However, these methods have disadvantages and
a high incidence of complications. Long-term results can
be unsatisfactory especially after resection of extensive or
juxta-articular tumours [2, 5–7].
Ilizarov introduced the concept of induction of local
bone formation with a minimally invasive procedure, the
process he called distraction osteogenesis (DO) [8]. DO has
been used widely to treat traumatic bone loss, nonunion,
osteomyelitis, malunion, limb-length discrepancy and to
correct deformity [9–12]. The method embraces biome-
chanical stability, minimally invasive surgery, regeneration
of new bone with gradual lengthening of the soft tissues
[5]. There are few studies of its use in the treatment of
benign bone tumours [13, 14]. In this study we describe our
experience of the use of external fixators to correct defor-
mity, limb-length discrepancy, contractures and similar
problems related to the primary treatment of benign bone
tumours or for the secondary complications of other pri-
mary treatment.
Materials and methods
Informed consent to participate in this study was obtained
from all patients and the Institutional Review Board
approved this study. External fixation techniques with or
without intramedullary nailing (IMN) were used in 26 bony
segments in 20 patients (10 males and 10 females) who had
been treated for benign bone tumours and subsequently
developed shortening, deformity or other complications.
The reconstruction procedures were performed in two
centres. The mean age at surgery was 17 years
(7–58 years). Physical examination of the affected limb
was complemented by plain radiography, computerized
tomography and magnetic resonance imaging as necessary.
The treatment was related to residual problems from the
tumour itself (primary treatment) in 8 patients and for
complications related to the primary surgery (secondary
treatment) in 12 patients. All problems were either defor-
mity or shortening, or both, or osteomyelitis.
Histological diagnoses included Ollier’s disease (OD) in
6 segments (four patients) (Figs. 1, 2, 3, 4, 5), fibrous
dysplasia (FD) in 8 (five patients) (Figs. 6, 7, 8, 9, 10, 11,
12), congenital multiple exostosis (CME) in 6 (five
patients) (Figs. 13, 14, 15, 16, 17, 18a, b), giant cell tumour
(GCT) in 2 (two patients), desmoid fibroma (DF) in 1 (one
patient), chondromyxoid fibroma (CMF) in 1 (one patient),
chondroma in 1 (one patient) and unicameral bone cyst
(UBC) in 1 (one patient) (Table 1).
A variety of fixation and reconstructive devices were
used to accomplish the objectives of surgery. Limb
lengthening was performed in three segments (one femur
was treated using the Ilizarov fixator, one tibia was treated
using the Ilizarov fixator with IM nailing and one tibia
using the Ilizarov fixator combined with ipsilateral femoral
IMN, both to compensate for limb discrepancy resulting
after primary tumour excision). Combined limb lengthen-
ing with deformity correction was performed in 22 seg-
ments (22/26). We used the Taylor Spatial Frame (TSF)
(Smith & Nephew, Memphis, TN, USA) to treat three
femurs and five tibias, and Smart correction (computer
assisted circular fixator system, Response Ortho, USA) to
treat four femurs. A unilateral fixator was applied to treat
one femur, one radius and four ulnas; Steinman pins were
used as intramedullary devices for two ulnar cases. EBI
Fig. 1 An eight-year-old girl with Ollier’s disease Lt. femur and tibia
who developed valgus deformity and shortening following initial
surgery of excision. Preoperative orthoroentgenogram denoting the
LLD and the valgus deformity
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external fixators (Dynafix; EBI, Parsippany, NJ, USA)
were used to treat one fibula and one humerus, the Ilizarov
fixator to treat one femur and a Multi-Axial Correction
(MAC) monolateral external fixator (Biomet, Parsippany,
NJ, USA) for one femur. Bone transport was performed in
one limb (the Ilizarov device was used to treat tibia by
bifocal compression distraction) (Table 1).
Prophylactic antibiotics were given to all patients for
2 days post-operatively. Distraction at the osteotomy site
was often started 7 days post-operatively, at a rate of
0.25 mm every 6 h, with radiographs every 2 weeks. A
rehabilitation programme of muscle and joint exercises was
initiated immediately after surgery.
The mean follow-up time was 69.5 months (range
35–108 months). A functional assessment was done using
criteria described by Paley et al. [15]. They are substantial
limp, equinus rigidity of the ankle, soft tissue dystrophy
(skin hypersensitivity, insensitivity of the sole, or decubitus
ulcer), pain and inactivity (unemployment because of the
leg injury or an inability to return to daily activities
because of the leg injury). The results were considered
Fig. 2 Tibial Ilizarov with proximal osteotomy for gradual length-
ening and distal osteotomy for gradual correction of valgus
Fig. 3 Clinical photo of the Ilizarov frame
Fig. 4 Femoral unilateral fixator for acute deformity correction and
gradual lengthening, note the consolidation of the regenerates with
corrected deformity
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excellent when the patient was active and had none of the
other four criteria, good when the patient was active and
had one or two of the other four criteria, fair when the
patient was active and had three or four of the other criteria
or had had an amputation, and poor when the patient is
inactive or had five criteria.
Results
The mean external fixation time was 159.5 days (range
27–300 days): 168 days in the OD group (129–210);
123.8 days in the FD group (51–152); 201 days in the
CME group (105–300); 148.5 days in the GCT group
(117–180); 90 days in the DF patient; 270 days in the CMF
patient; 210 days in the chondroma patient; 27 days in the
UBC patient. The mean length of distraction was 4.9 cm
(range 0.2–14 cm) (Tables 2, 3, 4, 5). This gave a mean
external fixation index of 67.4 days/cm (12–610) in 26
limbs that underwent distraction osteogenesis. This was
31.8 days/cm in the OD group (12–55), 140.4 days/cm in
the FD group (14–610), 62.2 days/cm in the CME group
(43–108), 28.5 days/cm in the GCT group (24–33),
26 days in the DF patient, 60 days in the CMF patient,
25 days in the chondroma patient and 39 days in the UBC
patient.
All 20 patients returned to normal daily activities
without pain at final follow-up. Only one patient with the
proximal tibial GCT had a knee arthrodesis due to sepsis
and prosthesis failure following initial surgery.
All patients were evaluated as excellent (using Paley’s
functional criteria) except one with DF who developed a
foot drop from sciatic nerve injury after initial surgery of
tumour excision; this was treated by pantalar arthrodesis.
Complications encountered included pin track infections in
6 patients which was treated by oral antibiotics, residual
shortening in 8 patients and diminished joint motion due to
knee arthrodesis in one patient.
Fig. 5 After removal of the fixators, restored length with deformity
correction
Fig. 6 A thirteen-year-old boy with Fibrous dysplasia Lt. distal
femur treated initially by excision. Clinically, block test denoting
5 cm shortening
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Discussion
Benign bone tumours are diagnosed in the juvenile age
group usually with the deformity and shortening encoun-
tered progressive. Correction of the deformity but ignoring
the limb shortening does not provide for a fully functional
extremity at maturity [16].
A number of surgical treatments are proposed for cor-
rection of deformity, limb-length equalization and recon-
struction in patients with bone tumours [16]. In this series
of patients with benign bone tumours, we were able to treat
most problems using external fixators. The aim was to
achieve normal physiological alignment at maturity, and
this may prompt a need for overcorrection and or over-
lengthening with distraction osteogenesis and the Ilizarov
method. Currently, whilst different devices are used for this
objective, the underlying principles are unchanged [16].
Multiple enchondromatosis (Ollier’s disease) is a com-
mon intraosseous benign cartilaginous tumour that devel-
ops in close proximity to the growth plate. It can cause
Fig. 7 AP orthoroentgenogram, denoting valgus deformity with the
CORA at the site of previous initial treatment
Fig. 8 Lateral X-ray of the same patient
Fig. 9 Immediately after the operation, with Smart correction
multiaxial frame and distal femoral osteotomy
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deformity and limb-length discrepancy and carries a risk of
malignant change to chondrosarcoma [17]. Conventional
treatment is curettage and bone grafting which may result
in severe deformities requiring repeated osteotomies. It is
often difficult to obtain adequate stabilization and normal
bone growth by autogenous bone grafting. Jesus-Garcia
et al. [18] reported the use of the Ilizarov method in ten
patients with Ollier’s disease. They reported excellent
results and claimed the technique led to conversion of the
abnormal cartilage to histologically mature bone in all their
patients [18]. In this series all cases had accurate deformity
correction with stable and mature bony regenerate. Three
of the four cases had residual shortening (0.5 cm) that was
not significant. One developed a knee contracture that
resolved with physiotherapy. In spite of lengthening, which
for some cases was over 9 cm and up to 14 cm, all four
patients had excellent bony healing illustrated by the low
EFI values (12, 23, 37 and 55 days/cm).
In fibrous dysplasia, curettage of the lesion and bone
grafting may be effective for monostotic lesions but not for
polyostotic fibrous dysplasia [19–21]. If the fibrous mate-
rial is curetted and replaced by autogenous bone chips,
these chips are often resorbed [22]. Curettage and bone
grafting is not suitable in patients with deformity and
pathological fracture. Corrective osteotomy with plate and
screw fixation is relatively simple, but it can be difficult to
achieve sufficient stability in fixation with screws in
weakened bone; additionally, a fracture may occur because
of stress shielding at the distal end of the plate [23].
Radical excisional surgery of the dysplastic bone will result
in deformity frequently and lead to functional losses that
can be of greater damage to the patient than the disease
itself. [24] In this series, surgical lengthening and align-
ment of the mechanical axis was effective in preventing
recurrent deformity and fracture. Of the five patients, four
had residual shortening (Fig. 12). Three cases developed
pin track infection during treatment which resolved com-
pletely using oral antibiotic therapy. The EFI in the FD
group is high (140.4 days/cm). The external fixation time
Fig. 10 After correction and lengthening with good regenerate (note
the amount of translation as the osteotomy site is not at the CORA)
Fig. 11 Orthoroentgenogram after removal of the frame with healed
regenerate and fully corrected limb
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and index can be decreased using a combined technique
such as an intramedullary nail and external fixator, but the
consistency of the fibrous lesions in this condition may lead
to technical difficulties in reaming and inserting an intra-
medullary nail into a long bone.
Congenital multiple exostosis (CMO) is characterized
by growths of multiple osteochondromas (benign cartilage-
capped bone tumours that grow outward from the
metaphyses of long bones). Osteochondromas can be
associated with an inhibition of skeletal growth, develop-
ment of bony deformities, restricted joint motion, short-
ened stature, premature osteoarthrosis, and compression of
peripheral nerves. Most individuals with CMO have at least
one operative procedure and many have multiple proce-
dures [25]. Femoral or tibial involvement often requires
surgical deformity correction and lengthening. Early sur-
gical treatment of tibio-talar tilt may prevent or decrease
the incidence of late deterioration of ankle function, but
long-term follow-up studies are needed to confirm [26].
Surgery for forearm deformity may involve excision of the
osteochondromas, corrective osteotomies, and or ulnar
lengthening procedures that may improve pronation,
supination, and forearm alignment [27]. Radial hemiepi-
physeal stapling, used alone or with ulnar lengthening, has
been effective but causes unacceptable shortening of the
Fig. 12 Clinically straight limb with the block test denoting residual
shortening
Fig. 13 A fourteen-year-old boy with Congenital Multiple Exostosis
Rt. Ulna treated initially by excision. X-ray showing type 1 deformity
in which there is ulnar deviation of the hand and deformity of the
radius
Fig. 14 Acutely corrected radius by plate and screws. Also unilateral
fixator in the ulna for gradual lengthening
Fig. 15 X-ray at the end of lengthening
Fig. 16 X-ray after removal of the external fixator, fully corrected
deformity with excellent regenerate (note the 0.5 over-lengthening to
avoid complications of recurrence and to improve the function
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forearm and the final result unpredictable [28]. In this
series, the main problems in the three cases included ulnar
deviation of the hand and deformity of the radius. After
prior resection of the osteochondroma, ulnar lengthening
was carried out with an external unilateral fixator con-
comitant with a corrective osteotomy of the radius with
plate and screw fixation; there were satisfactory results and
complete restoration of length of the ulna. We opted to
perform over-lengthening by 0.5 cm in all the three cases
to avoid recurrence of the ulna-radial length mismatch and
to maintain improved function for longer (Fig. 16). One of
these patients developed a recurrent radial deformity. The
last two patients in this group had, in addition, femoral
deformity and shortening which were treated successfully
with using the Smart correction multiaxial fixator. One
centimetre of residual shortening resulted in both cases.
The approach to treating giant cell tumours (GCT) has
remained unchanged partly due to the lack of randomized
clinical trials [29]. Surgery is the treatment of choice if the
tumour is determined to be resectable. A number of
strategies have been advocated including: curettage and
grafting with autogenous bone graft; allograft or synthetic
bone substitutes; either graft alone or combined with
adjuvant therapy such as cryotherapy or the application of
phenol after curettage [30–34]. Curettage is the commonly
used technique [35], but it has reported recurrence rates of
27–55 % [36]. This high rate of recurrence is likely from
an inadequate tumour resection rather than the use of
adjuvant therapy [38]. Nonetheless, the high risk of
recurrence led several surgeons to replace bone graft
packing of the lesion with Poly Methyl Methacrylate
(PMMA). The PMMA technique, compared with bone
grafting, offers the advantages of lack of donor-site mor-
bidity, an unlimited supply, immediate structural stability,Fig. 17 Photographic documentation during external fixation period
Fig. 18 a, b Photographic documentation denoting fully corrected deformity and functional limb
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low cost and ease of use. In addition, the barium contained
in the methylmethacrylate results in a radiopaque substance
that sharply contrasts with the surrounding bone. Local
recurrences are more readily apparent than in cases in
which bone graft is used [35]. However, there has disad-
vantages such as a thermal effect on articular cartilage,
degenerative arthritis and that PMMA is not a biological
substrate [37]. In this series there were two patients with
GCT. One lesion located in the proximal tibia was man-
aged initially by resection and prosthetic replacement. This
became infected and was removed and followed by a
course of antibiotics. The limb was then salvaged and the
bone defect treated by knee arthrodesis, tibial Ilizarov and
femoral lengthening over nail (LON). The second lesion
was located in the distal radius. The patient developed a
recurrence and osteomyelitis in the fibular graft used in the
primary treatment. This was treated with further resection
and distraction osteogenesis until both length and defor-
mity were corrected.
Meary et al. in their nineteen cases of desmoid fibroma
of the limbs noticed a large number of recurrences after
surgical excision [39]. They concluded that treatment based
on surgical excision should be as extensive as possible
which leads usually to deformity and shortening. There was
one patient with a desmoid fibroma affecting gluteal region
and the tibia. After initial tumour excision, the patient
developed shortening and a sciatic nerve palsy. This
complication was addressed using the Ilizarov fixator and
an IM nail for tibial lengthening and a pantalar arthrodesis
to correct the foot drop. A residual shortening of 2 cm was
the end result.
Chondromyxoid fibroma (CMF) is one of the rarest of
bone tumours, accounting for less than 1 % of all bone
tumours. The tumour is more common in males and located
mostly in the metaphyseal areas of the lower extremity
[40]. The most common method of treating CMF is with
curettage followed by autograft or allograft. Occasionally,
additional chemicals, such as phenol or liquid nitrogen, are
placed inside the bone cavity to try to reduce the risk of
recurrence. Lersundi et al., in their thirty cases of CMF,
concluded that tumours treated with curettage alone did
less well than those that were packed with allograft bone or
polymethylmethacrylate and those treated by excision did
not recur [40]. There was one patient with CMF in the
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acetabulum in this series. Initial treatment of resection led
to shortening which was treated by femoral lengthening
using the Ilizarov fixator.
The chondroma is a self-limiting lesion that, in most of
cases, heals spontaneously with no treatment required for
asymptomatic lesions. However, if a pathological fracture
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occurs it is treated with curettage and bone grafting [41].
The patient from this series was treated initially by wide
resection for a distal femoral chondroma. The Ilizarov
fixator was applied for deformity correction and length-
ening; a residual 0.5 cm shortening was the outcome.
Despite an extensive literature on the unicameral bone
cyst (UBC), there remains an uncertainty regarding optimal
treatment. Bensahel et al. [42] have stated the solitary bone
cyst has not revealed all its secrets. Surgical therapy of a
UBC may be divided into open and percutaneous proce-
dures. Success is quite varied and the very definition of
success has also varied amongst authors [43]. The initial
treatment of the patient with UBC of the distal fibula in this
series was of curettage and bone grafting, after which
shortening and deformity occurred. We applied EBI
monolateral fixator for lengthening and deformity
correction.
There is a concern regarding the risk for malignant
degeneration in patients when an osteotomy is performed
in bone with a coexisting benign tumour [5]. Similarly,
there are concerns over the quality of new bone formation
during distraction osteogenesis in what is ‘diseased’ bone
[5]. Despite these concerns, we did not encounter these
problems during a mean follow-up of 69.5 months.
Conclusion
There are advantages of using distraction osteogenesis in
the treatment of problems and sequelae after primary
treatment for benign bone tumours. The risks for recur-
rence of shortening and deformity in young patients may be
minimized with overcorrection or over-lengthening. There
appears to be no increased risk of malignant degeneration
from osteotomy through diseased bone or there being low-
quality regenerate bone at the distraction site. We believe
that external fixation is an effective technique for treating
defects, problems and complications related to benign bone
tumours or the effects arising from wide excision of the
primary lesion. It offers a good alternative to other con-
ventional methods of management. There are some disad-
vantages to this technique such as pin track infection, the
bulk and encumbrance of the fixator and the prolonged
treatment period. The choice of external fixator is dictated
by the complexity of problem and the anatomical location
but, in general, the circular fixators are more suitable than
the unilateral fixators for the simultaneous treatment of
deformity and limb-length discrepancy.
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